Cadrenal Therapeutics, Inc. (CVKD)
NASDAQ: CVKD · Real-Time Price · USD
12.41
-0.55 (-4.24%)
At close: Sep 2, 2025, 4:00 PM
12.17
-0.24 (-1.93%)
After-hours: Sep 2, 2025, 7:43 PM EDT
Cadrenal Therapeutics Market Cap
Cadrenal Therapeutics has a market cap or net worth of $25.40 million as of September 2, 2025. Its market cap has increased by 205.73% in one year.
Market Cap
25.40M
Enterprise Value
19.83M
1-Year Change
205.73%
Ranking
Category
Stock Price
$12.41
Market Cap Chart
Since the IPO on January 20, 2023, Cadrenal Therapeutics's market cap has decreased from $58.17M to $25.40M, a decrease of -56.33%. That is a compound annual growth rate of -27.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 26.53M | 2.71% |
| Dec 31, 2024 | 25.83M | 168.05% |
| Dec 29, 2023 | 9.64M | -83.44% |
| Jan 20, 2023 | 58.17M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 249.87B |
| AstraZeneca | 246.96B |
| Novartis AG | 244.78B |
| Abbott Laboratories | 230.89B |